Nuremberg, Germany

Volker Pfanhlert


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Volker Pfanhlert: Innovator in Pharmaceutical Chemistry

Introduction

Volker Pfanhlert is a notable inventor based in Nuremberg, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzimidazoles. His research has led to the development of new compounds that have potential therapeutic applications.

Latest Patents

Pfanhlert holds a patent for "Benzimidazoles and pharmaceutical preparations containing these compounds." This patent describes new benzimidazoles corresponding to a specific general formula, where various substituents can be attached to the benzimidazole ring. The compounds are characterized as effective, positive inotropic substances that do not operate through phosphodiesterase inhibition. This innovation represents a significant advancement in the development of new pharmaceutical agents.

Career Highlights

Volker Pfanhlert is associated with Heumann Pharma GmbH & Co., where he has been instrumental in advancing pharmaceutical research. His work has not only contributed to the company's portfolio but has also enhanced the understanding of benzimidazole compounds in the medical field.

Collaborations

Pfanhlert has collaborated with notable colleagues such as Peter Morsdorf and Helmut Schickaneder. These collaborations have fostered a productive research environment, leading to innovative solutions in pharmaceutical chemistry.

Conclusion

Volker Pfanhlert's contributions to the field of pharmaceutical chemistry through his patent on benzimidazoles highlight his role as an influential inventor. His work continues to pave the way for new therapeutic options in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…